Ynto S. de Boer

University of Amsterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Joost P. H. Drenth

Radboud University Medical Center

NETHERLANDS

View details

Guruprasad P. Aithal

UNITED KINGDOM

View details

Xavier Verhelst

Associate Professor of Hepatology

Ghent University

BELGIUM

View details

Bart van Hoek

Professor of Hepatology

Leiden University

NETHERLANDS

View details

David Kleiner

National Cancer Institute

UNITED STATES

View details

Ye Htun Oo

University of Birmingham

UNITED KINGDOM

View details

Hans Van Vlierberghe

Ghent University Hospital

BELGIUM

View details

Ellina Lytvyak

Assistant Professor

University of Alberta

CANADA

View details

Christoph Schramm

Professor

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Mariana Cardoso

Hospital Professor Doutor Fernando Fonseca EPE

PORTUGAL

View details

Elisabeth Bloemena

Professor of Oral Pathology

Academic Center for Dentistry Amsterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ynto S. de Boer

Research Interests

Explore related searches

Contact this professor

Articles (14)

Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-analysis

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry

Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome—First report of the IAIHG retrospective registry

Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome—First report of the IAIHG retrospective registry

MAdCAM-1 does not play a central role in the early pathophysiology of autoimmune hepatitis.

Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis.

Current landscape of therapeutic EUS: Changing paradigms in gastroenterology practice.

Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study

Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis

Established and novel therapeutic options for autoimmune hepatitis

Collaborators (11)

Joost P. H. Drenth

Guruprasad P. Aithal

Xavier Verhelst

Bart van Hoek

David Kleiner

Ye Htun Oo

Hans Van Vlierberghe

Ellina Lytvyak

Christoph Schramm

Mariana Cardoso

Elisabeth Bloemena

Make your next move.